Company news
Adocia Sa (EURONEXT:ADOC) news
Every Adocia Sa press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
Number of Shares and Voting Rights of ADOCIA as of August 31st, 2026
September 10, 2026
ADOCIA Announces Changes in its Board of Directors with the Appointment of a New Director and a Board Observer
September 1, 2026
Number of Shares and Voting Rights of ADOCIA as of July 31st, 2026
August 24, 2026
ADOCIA Reports Second Quarter 2026 Financial Results and Provides a Business Update
July 23, 2026
Number of Shares and Voting Rights of ADOCIA as of June 30, 2026
July 7, 2026
ADOCIA Announces the Expiration of Exclusive Right to Negotiate Partnership for M1Pram with SANOFI
July 3, 2026
Number of Shares and Voting Rights of ADOCIA as of May 31st, 2026
June 11, 2026
ADOCIA Announces THDB0206 (BioChaperone® Lispro) Phase 3 Data in Type 2 Diabetes Presented at ADA 86th Scientific Sessions, Confirming th...
June 8, 2026
Adocia Announces a Virtual KOL Event to Review the Phase 3 Results of the Ultra-Rapid Insulin BioChaperone® Lispro on June 16, 2026
June 4, 2026
ADOCIA Reports First Quarter 2026 Financial Results and Provides a Business Update
May 12, 2026
ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 3rd, 2026 in Paris
May 11, 2026
ADOCIA Announces the Release of its Universal Registration Document for the Year 2025
April 29, 2026
ADOCIA Announces Full Year 2025 Financial Results and Provides a Corporate and Financial Update
April 21, 2026
ADOCIA and Vester Finance sign a shareholder loan agreement, enabling ADOCIA to extend its cash runway until beginning Q2 2027
April 21, 2026
ADOCIA Reports Fourth Quarter 2025 Financial Results and Provides a Business Update
February 24, 2026
ADOCIA Announces Half-Year Report on Adocia’s Liquidity Agreement with Kepler Capital Markets
January 22, 2026
ADOCIA Announces its Financial Calendar for 2026
December 18, 2025
ADOCIA Announces the Completion of a €10 Million Fundraising
December 4, 2025
ADOCIA Announces Filing of Patent for New Long-Acting Peptides Platform in Diabetes and Obesity - AdoXLong™ - and Provides an Update on i...
November 12, 2025
ADOCIA Reports Third Quarter 2025 Financial Results and Provides a Business Update
October 15, 2025
ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0...
October 15, 2025
ADOCIA Announces First Half 2025 Financial Results and Provides a Business Update
September 25, 2025
ADOCIA Announces Oral Presentations on AdoShell® and BioChaperone® at EASD, ESB and PODD 2025 Annual Meetings
September 3, 2025
ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0...
July 25, 2025
ADOCIA Reports Second Quarter 2025 Financial Results and Provides a Business Update
July 23, 2025
ADOCIA Presentations at ADA & IPITA Scientific Conferences Highlight Scalability and Good Translation of AdoShell® from Human Islets to S...
June 24, 2025
ADOCIA Confirms its Eligibility for the PEA‑PME Scheme
May 22, 2025
ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 11th, 2025 in Paris
May 21, 2025
ADOCIA Reports First Quarter 2025 Financial Results and Provides a Business Update
May 14, 2025
ADOCIA to Present New Data on AdoShell® at Upcoming Scientific Conferences – Showcasing Potential Curative Treatment for Type 1 Diabetes
April 28, 2025